Kindred Healthcare, Inc. (KND) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Kindred Healthcare, Inc. (NYSE:KND) have been assigned an average recommendation of “Hold” from the ten ratings firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $9.75.
KND has been the subject of several recent research reports. Zacks Investment Research lowered Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, February 21st. Mizuho increased their price objective on Kindred Healthcare from $5.00 to $8.50 and gave the stock a “neutral” rating in a report on Tuesday, February 28th. Royal Bank Of Canada reiterated a “hold” rating and set a $10.00 price objective on shares of Kindred Healthcare in a report on Friday, May 5th. Finally, Barclays PLC reiterated a “buy” rating and set a $13.00 price objective (up from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th.
A number of institutional investors have recently bought and sold shares of KND. A.R.T. Advisors LLC acquired a new position in Kindred Healthcare during the fourth quarter valued at approximately $759,000. InterOcean Capital LLC acquired a new position in Kindred Healthcare during the fourth quarter valued at approximately $157,000. Renaissance Technologies LLC increased its position in Kindred Healthcare by 33.7% in the fourth quarter. Renaissance Technologies LLC now owns 259,280 shares of the health services provider’s stock valued at $2,035,000 after buying an additional 65,400 shares during the last quarter. Gamco Investors INC. ET AL increased its position in Kindred Healthcare by 18.4% in the fourth quarter. Gamco Investors INC. ET AL now owns 225,046 shares of the health services provider’s stock valued at $1,767,000 after buying an additional 35,000 shares during the last quarter. Finally, Gabelli Funds LLC increased its position in Kindred Healthcare by 4.4% in the fourth quarter. Gabelli Funds LLC now owns 588,356 shares of the health services provider’s stock valued at $4,619,000 after buying an additional 24,981 shares during the last quarter. 91.08% of the stock is currently owned by hedge funds and other institutional investors.
Kindred Healthcare (NYSE:KND) traded up 2.36% during midday trading on Tuesday, reaching $10.85. The company’s stock had a trading volume of 812,583 shares. The firm’s market capitalization is $929.12 million. Kindred Healthcare has a 12 month low of $5.65 and a 12 month high of $12.55. The stock’s 50-day moving average price is $10.17 and its 200-day moving average price is $8.41.
Kindred Healthcare (NYSE:KND) last announced its quarterly earnings data on Wednesday, May 3rd. The health services provider reported $0.04 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.04. Kindred Healthcare had a positive return on equity of 4.08% and a negative net margin of 9.55%. The business had revenue of $1.77 billion during the quarter, compared to analyst estimates of $1.78 billion. Analysts predict that Kindred Healthcare will post $0.53 EPS for the current year.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.